Isolation of a urinary digitalis-like factor indistinguishable from digoxin
The interface residue Trp114 hTrxR1 is solvent exposed in uncomplexed hTrxR1 structures, but it is interlocked with several Trx-residues in the complex structure (Figs 4 and 6)
XOI-based ULT effects on serum metabolomic profiling
A Brave New World: Therapeutic Area Deep Dives on Obesity This blog is the first of a new series exploring a range of topics in the obesity market, including: market size and scope, impact of payer controls, activity in non-traditional channels, patient behavior, GLP-1 impact, HCP responses, the policy landscape, pharmacy economics, and the outlook for the future of GLP-1
Cramer was impressed that the panel of 11 came to the decision that donanemab's benefits outweighed its risks
What makes a provider the best tirzepatide online option